Non-atherosclerotic myocardial infarction in hypereosinophilic syndrome: emerging insights and therapeutic approaches

It is important to note that MI associated with HEC is fundamentally different from MI caused by atherosclerosis in pathogenesis, diagnosis, and treatment. This paradigm shift allows us to take a fresh look at the diagnosis of cardiovascular diseases and suggests targeted treatment strategies for non-atherosclerotic MI. The scientists summarized current knowledge about MI associated with HEC, with an emphasis on its unique epidemiology, pathophysiology, evidence-based diagnostic criteria, and specific treatment methods, and discussed priorities for future research to advance clinical research.

 

 

 

doi.org/10.1136/heartjnl-2025-326273